论文部分内容阅读
自1989年国外建立了血清丙型肝炎病毒抗体(抗HCV)检测方法以来,文献中报道大部分慢性肝炎、肝硬化及肝癌患者血清中可检出抗HCV。但对常见恶性肿瘤中丙型肝炎病毒(HCV)感染的情况报道甚少。本文对401例确诊为恶性肿瘤的住院患者进行了抗HCV检测,希图了解HCV感染与常见恶性肿瘤的关系,并对试验结果及实验过程中的有关问题进行分析。 材料与方法 一、检测对象 1991年12月以来确诊为恶性肿瘤的住院患者401例,其中男255例,女146例,年龄最小12岁,最大70岁,平均年龄34.14±10.32。401例患者中肝癌67例,乳腺癌59例,肺癌54例,结肠癌46例,恶性淋巴瘤32例,宫颈癌32例,胃癌
Since the establishment of a serum HCV antibody (anti-HCV) test in foreign countries in 1989, it has been reported in the literature that anti-HCV can be detected in the serum of most patients with chronic hepatitis, cirrhosis and liver cancer. However, few reports have been reported on the prevalence of hepatitis C virus (HCV) infection in common malignancies. In this paper, 401 cases of hospitalized patients diagnosed with malignant tumors were tested for anti-HCV, trying to understand the relationship between HCV infection and common malignancies, and the experimental results and experimental analysis of the relevant issues. Materials and methods First, the test object 401 cases of malignant tumors hospitalized since December 1991, including 255 males and 146 females, the youngest 12 years old, maximum 70 years old, the average age was 34.14 ± 10.32.401 patients 67 cases of liver cancer, 59 cases of breast cancer, 54 cases of lung cancer, 46 cases of colon cancer, 32 cases of malignant lymphoma, 32 cases of cervical cancer, gastric cancer